Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	27239
Country	Netherlands

Received	2016-05-19 09:29
Peer-Review Started	2016-05-19 14:00
To Make the First Decision	2016-06-06 10:45
Return for Revision	2016-06-07 11:47
Revised	2016-07-06 05:22
Second Decision	2016-07-28 08:24
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-08-08 14:26
Articles in Press	2016-08-08 14:26
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-10-19 08:41
Publish the Manuscript Online	2016-10-25 16:05

ISSN	1948-9366 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Clinical Trials Study
Article Title	Phase Ⅱ study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer
Manuscript Source	Invited Manuscript
All Author List	Anneriet E Dassen, Nienke Bernards, Valery EPP Lemmens, Yes AJ van de Wouw, Koop Bosscha, Geert-Jan Creemers and Hans JFM Pruijt
Funding Agency and Grant Number
Corresponding Author	Anneriet E Dassen, MD, PhD, Department of Gastrointestinal Surgery and Surgical Oncology, Jeroen Bosch Hospital, PO Box 90153, 5200 ME’s-Hertogenbosch, The Netherlands. a.dassen@erasmusmc.nl
Key Words	Gastric cancer; Preoperative chemotherapy; Docetaxel; Capecitabine
Core Tip	The use of the combination of docetaxel, cisplatin and capecitabine in resectable gastric cancer has resulted in a high curative resection rate of 77%, although it also resulted in a high rate of febrile neutropenia, and in treatment related mortality.
Publish Date	2016-10-25 16:05
Citation	Dassen AE, Bernards N, Lemmens VEPP, van de Wouw YAJ, Bosscha K, Creemers GJ, Pruijt HJFM. Phase Ⅱ study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer. World J Gastrointest Surg 2016; 8(10): 706-712
URL	http://www.wjgnet.com/1948-9366/full/v8/i10/706.htm
DOI	http://dx.doi.org/10.4240/wjgs.v8.i10.706

Full Article (PDF)	WJGS-8-706.pdf
Full Article (Word)	WJGS-8-706.doc
Manuscript File	27239-Review.doc
Answering Reviewers	27239-Answering reviewers.pdf
Audio Core Tip	27239-Audio core tip.mp3
Clinical Trial Registration Statement	27239-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form	27239-Conflict-of-interest statement.pdf
Copyright License Agreement	27239-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	27239-Clinical trial registration statement.pdf
Institutional Review Board Approval Form or Document	27239-Institutional review board statement.pdf
Peer-review Report	27239-Peer-review(s).pdf
Scientific Misconduct Check	27239-Scientific misconduct check.pdf
Scientific Editor Work List	27239-Scientific editor work list.pdf